Grab Holdings Limited is upgraded to Strong Buy due to accelerating inflection, robust growth, and attractive valuation. Read more on GRAB stock here.

A wave of companies embraced Michael Saylor’s bitcoin playbook in 2025. But with prices plummeting, investors are now sorting bargains from balance-sheet traps.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2025 Earnings Call Transcript February 17, 2026 Halozyme Therapeutics, Inc.

Based on the information provided by these holders, the Company currently understands that an aggregate of 9,375 Series D ...

SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for ...

Following publication of the Bilboes Feasibility Study in November 2025 1 Caledonia has moved quickly to start to implement a four-part funding plan designed to ensure the project can be advanced at ...

Michael Saylor said on Sunday that Strategy (previously known as Microstrategy) plans to convert roughly $6 billion of its convertible debt into equity over the next three to six years, aiming to ...

A mandatory convertible bond requires conversion into common stock by a set date. Learn how this financial instrument works and its potential benefits for investors.

Esperion Therapeutics, Inc. is rated a Hold with robust growth, a strong balance sheet, and modest revenue. Learn more about ...

So we are not focusing on Go as a product by itself, but actually taking the assets Ofer Katz: that we have developed for that project Micha Kaufman: and integrating them into the customer experience.